Publicacions en què col·labora amb Irene Villalón García (24)

2023

  1. Alpha-lipoic acid supplementation corrects pathological alterations in cellular models of pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels

    Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 80

  2. Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration

    Neural Regeneration Research, Vol. 18, Núm. 6, pp. 1196-1202

2022

  1. Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?

    Biomedicines, Vol. 10, Núm. 7

  2. Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming

    Cellular reprogramming, Vol. 24, Núm. 5, pp. 294-303

  3. Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome

    Genes, Vol. 13, Núm. 12

  4. Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases

    Frontiers in Pharmacology, Vol. 13

  5. Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels

    Orphanet journal of rare diseases, Vol. 17, Núm. 1, pp. 311

  6. UPRmt activation improves pathological alterations in cellular models of mitochondrial diseases

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  7. Vitamin E prevents lipid peroxidation and iron accumulation in PLA2G6-Associated Neurodegeneration

    Neurobiology of Disease, Vol. 165

2021

  1. Coenzyme q10 analogues: Benefits and challenges for therapeutics

    Antioxidants, Vol. 10, Núm. 2, pp. 1-20

  2. Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  3. From mitochondria to atherosclerosis: The inflammation path

    Biomedicines, Vol. 9, Núm. 3, pp. 1-24

  4. Mitochondria and antibiotics: For good or for evil?

    Biomolecules, Vol. 11, Núm. 7

2020

  1. Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients’ Brain in a Dish

    Frontiers in Genetics, Vol. 11

  2. Coenzyme q10: Novel formulations and medical trends

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-23

  3. Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 6

2019

  1. Atherosclerosis and coenzyme q10

    International Journal of Molecular Sciences, Vol. 20, Núm. 20

  2. Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation

    Molecular Neurobiology, Vol. 56, Núm. 5, pp. 3638-3656

  3. Pathophysiological characterization of MERRF patient-specific induced neurons generated by direct reprogramming

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1866, Núm. 5, pp. 861-881

  4. Precision medicine in pantothenate kinase-associated neurodegeneration

    Neural Regeneration Research, Vol. 14, Núm. 7, pp. 1177-1185